| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1101304975 |
| P356 | DOI | 10.1186/S12974-018-1103-Y |
| P932 | PMC publication ID | 5831753 |
| P698 | PubMed publication ID | 29495967 |
| P50 | author | Eduardo Munoz | Q51676809 |
| Francisco Carrillo-Salinas | Q56241066 | ||
| Leyre Mestre | Q59680276 | ||
| Bernd L Fiebich | Q59830121 | ||
| Ana Feliú | Q85585590 | ||
| Carmen Navarrete | Q96065802 | ||
| Marco A Calzado | Q40017958 | ||
| P2093 | author name string | Giovanni Appendino | |
| Carmen Guaza | |||
| Miriam Mecha | |||
| Belén Palomares | |||
| Carla Jiménez-Jiménez | |||
| Maria L Bellido | |||
| P2860 | cites work | A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation | Q24294741 |
| Cellular response to hypoxia involves signaling via Smad proteins | Q24314797 | ||
| Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1 | Q24336199 | ||
| Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein | Q24599442 | ||
| Cannabidiol, a non-psychoactive cannabinoid compound, inhibits proliferation and invasion in U87-MG and T98G glioma cells through a multitarget effect | Q28534561 | ||
| A cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitis | Q28537808 | ||
| Axonal transection in the lesions of multiple sclerosis | Q29615585 | ||
| The blood-brain barrier in health and chronic neurodegenerative disorders | Q29616411 | ||
| Remyelination in the CNS: from biology to therapy | Q30040587 | ||
| Neurogenesis, angiogenesis, and MRI indices of functional recovery from stroke | Q31096458 | ||
| Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis | Q33642743 | ||
| Pharmacological Modulation of Functional Phenotypes of Microglia in Neurodegenerative Diseases | Q33679220 | ||
| Differential activation and antagonistic function of HIF-{alpha} isoforms in macrophages are essential for NO homeostasis | Q33685179 | ||
| Monoamine oxidase A upregulated by chronic intermittent hypoxia activates indoleamine 2,3-dioxygenase and neurodegeneration | Q33784147 | ||
| Oligodendrocyte precursors migrate along vasculature in the developing nervous system | Q33802579 | ||
| The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination | Q33817395 | ||
| Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis. | Q34109028 | ||
| Glucocorticoid protection of oligodendrocytes against excitotoxin involving hypoxia-inducible factor-1alpha in a cell-type-specific manner. | Q34125992 | ||
| Why does remyelination fail in multiple sclerosis? | Q34147437 | ||
| A cannabigerol quinone alleviates neuroinflammation in a chronic model of multiple sclerosis. | Q34299290 | ||
| Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases | Q34657382 | ||
| Vascular endothelial growth factor regulates the migration of oligodendrocyte precursor cells | Q35132539 | ||
| Ligand and receptor dynamics contribute to the mechanism of graded PPARγ agonism. | Q35753031 | ||
| Rosiglitazone infusion therapy following minimally invasive surgery for intracerebral hemorrhage evacuation decreases matrix metalloproteinase-9 and blood-brain barrier disruption in rabbits | Q35755262 | ||
| A Sativex(®) -like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis | Q35865445 | ||
| Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa | Q36339991 | ||
| CDK-dependent phosphorylation of PHD1 on serine 130 alters its substrate preference in cells | Q36518627 | ||
| The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways | Q36591533 | ||
| Cannabinoid receptor 2 counteracts interleukin-17-induced immune and fibrogenic responses in mouse liver | Q50867754 | ||
| Protective effects of angiopoietin-like 4 on cerebrovascular and functional damages in ischaemic stroke | Q50993557 | ||
| Induction of vascular remodeling: a novel therapeutic approach in EAE. | Q52641817 | ||
| PPARγ Activation Primes Human Monocytes into Alternative M2 Macrophages with Anti-inflammatory Properties | Q57244208 | ||
| Effects of the pyrones, maltol and ethyl maltol, on iron absorption from the rat small intestine | Q69898207 | ||
| Inducible nitric oxide synthase gene expression and enzyme activity correlate with disease activity in murine experimental autoimmune encephalomyelitis | Q71941640 | ||
| Signal transduction by vascular endothelial growth factor receptors | Q84520249 | ||
| INF-β1b therapy modulates L-arginine and nitric oxide metabolism in patients with relapse remittent multiple sclerosis | Q95423993 | ||
| Neuroprotection via matrix-trophic coupling between cerebral endothelial cells and neurons. | Q36677211 | ||
| Multiple sclerosis: a complicated picture of autoimmunity. | Q36915907 | ||
| Neurovascular signalling defects in neurodegeneration | Q37078102 | ||
| An oligovascular niche: cerebral endothelial cells promote the survival and proliferation of oligodendrocyte precursor cells | Q37361396 | ||
| The nuclear receptor PPAR gamma selectively inhibits Th17 differentiation in a T cell-intrinsic fashion and suppresses CNS autoimmunity | Q37377446 | ||
| Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS | Q37531460 | ||
| Epigenome-wide differences in pathology-free regions of multiple sclerosis-affected brains | Q37602769 | ||
| Preconditioning provides neuroprotection in models of CNS disease: paradigms and clinical significance. | Q37607849 | ||
| Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models | Q37617710 | ||
| Adrenomedullin protects from experimental autoimmune encephalomyelitis at multiple levels | Q37633526 | ||
| The mTOR and PP2A Pathways Regulate PHD2 Phosphorylation to Fine-Tune HIF1α Levels and Colorectal Cancer Cell Survival under Hypoxia. | Q37654508 | ||
| A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells | Q37681196 | ||
| M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination | Q37687158 | ||
| Polarization of macrophages and microglia in inflammatory demyelination | Q38096246 | ||
| Transcriptional control of macrophage polarization | Q38103800 | ||
| Inhibition of hypoxia-inducible factor prolyl hydroxylase domain oxygen sensors: tricking the body into mounting orchestrated survival and repair responses | Q38131530 | ||
| Macrophages and CNS remyelination | Q38193884 | ||
| Alternatively activated microglia and macrophages in the central nervous system. | Q38525488 | ||
| Cannabidiol protects an in vitro model of the blood-brain barrier from oxygen-glucose deprivation via PPARγ and 5-HT1A receptors | Q38572902 | ||
| Recent Advances in Developing Inhibitors for Hypoxia-Inducible Factor Prolyl Hydroxylases and Their Therapeutic Implications. | Q38648760 | ||
| Vascular endothelial growth factor: a neurovascular target in neurological diseases | Q38882640 | ||
| HIF-mediated innate immune responses: cell signaling and therapeutic implications | Q38989126 | ||
| An inducible autoregulatory loop between HIPK2 and Siah2 at the apex of the hypoxic response. | Q39910695 | ||
| Preconditioning with cobalt chloride or desferrioxamine protects oligodendrocyte cell line (MO3.13) from tumor necrosis factor-alpha-mediated cell death | Q39988082 | ||
| Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells | Q40570664 | ||
| Production of cAMP by adrenomedullin in human oligodendroglial cell line KG1C: comparison with calcitonin gene-related peptide and amylin | Q40763413 | ||
| Pharmacological inhibition of Akt and downstream pathways modulates the expression of COX-2 and mPGES-1 in activated microglia | Q41362782 | ||
| Erythropoietin reduces experimental autoimmune encephalomyelitis severity via neuroprotective mechanisms. | Q42377441 | ||
| Clinical Tolerogenic Dendritic Cells: Exploring Therapeutic Impact on Human Autoimmune Disease | Q42694613 | ||
| A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules. | Q44124410 | ||
| Angiogenic and vasoprotective effects of adrenomedullin on prevention of cognitive decline after chronic cerebral hypoperfusion in mice | Q44570243 | ||
| Bevacizumab diminishes experimental autoimmune encephalomyelitis by inhibiting spinal cord angiogenesis and reducing peripheral T-cell responses | Q44916496 | ||
| Hypoxia controls CD4+CD25+ regulatory T-cell homeostasis via hypoxia-inducible factor-1alpha | Q44948359 | ||
| Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis. | Q45086893 | ||
| Hypoxia-induced secretion of TGF-β1 in mesenchymal stem cell promotes breast cancer cell progression. | Q45947919 | ||
| Erythropoietin prevents the increase in blood-brain barrier permeability during pentylentetrazol induced seizures | Q46847178 | ||
| Endothelial trophic support of neuronal production and recruitment from the adult mammalian subependyma. | Q48176770 | ||
| The relationship between erythropoietin pretreatment with blood-brain barrier and lipid peroxidation after ischemia/reperfusion in rats | Q48272938 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 1 | |
| P921 | main subject | multiple sclerosis | Q8277 |
| cannabidiol | Q422917 | ||
| cannabinoids | Q422936 | ||
| P304 | page(s) | 64 | |
| P577 | publication date | 2018-03-01 | |
| P1433 | published in | Journal of Neuroinflammation | Q15716679 |
| P1476 | title | Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy. | |
| P478 | volume | 15 |
| Q90464649 | Altered secretory and neuroprotective function of the choroid plexus in progressive multiple sclerosis |
| Q89597089 | Cannabinoids in the Pathophysiology of Skin Inflammation |
| Q89965047 | Endocannabinoid Modulation of Microglial Phenotypes in Neuropathology |
| Q61812460 | Facets of Theiler's Murine Encephalomyelitis Virus-Induced Diseases: An Update |
| Q92239441 | Immunoregulatory Interplay Between Arginine and Tryptophan Metabolism in Health and Disease |
| Q90163998 | Reappraisal of Human HOG and MO3.13 Cell Lines as a Model to Study Oligodendrocyte Functioning |
| Q58775742 | Traditional Uses of Cannabinoids and New Perspectives in the Treatment of Multiple Sclerosis |
| Q58091922 | VCE-004.8, A Multitarget Cannabinoquinone, Attenuates Adipogenesis and Prevents Diet-Induced Obesity |
Search more.